Pulmatrix, Inc. current report, 13 July 2023

Full document

Pulmatrix, Inc. 8-K Summary

Business Context and Reporting Period

This Form 8-K reports the results of the 2023 Annual Meeting of Stockholders held by Pulmatrix, Inc. on July 13, 2023. The meeting constituted a quorum with 2,181,919 shares present, representing 59.74% of outstanding common stock entitled to vote.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.

Material Changes and Voting Results

The following matters were submitted to a vote of security holders:

  • Election of Directors: Two Class III directors were elected to serve until the 2026 annual meeting.
    • Michael J. Higgins: 758,720 votes For; 533,500 votes Withheld/Abstained.
    • Anand Varadan: 1,014,129 votes For; 278,091 votes Withheld/Abstained.
  • Ratification of Auditors: Marcum LLP was ratified as the independent registered public accounting firm for the 2023 fiscal year.
    • 1,860,275 votes For; 251,489 votes Against; 70,155 votes Withheld/Abstained.
  • Executive Compensation (Say-on-Pay): The advisory vote on named executive officer compensation was approved.
    • 603,083 votes For; 565,062 votes Against; 124,075 votes Withheld/Abstained.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. For further details on the proposals, the filing references the definitive proxy statement filed on June 2, 2023.

Key Facts for Investor Verification

  • Verify the final voting percentages for the Say-on-Pay proposal, which received a narrow margin of approval (For votes exceeded Against votes by approximately 38,000 shares).
  • Confirm the total number of broker non-votes (889,699) which were excluded from the vote totals for director elections and executive compensation.
  • Review the definitive proxy statement filed on June 2, 2023, for detailed biographies of the elected directors and the specific compensation metrics approved.